Navitas Life Sciences

5 key trends in the biologics and biosimilars market 2021

Authored by our Global Head of Generics, Dr. Ayaaz Hussain Khan, this article explores the meteoric rise of the biosimilar market, expected to reach $240 billion by 2030 and takes a deep dive into the 5 key trends that we are witnessing for 2021.

Please complete the form to download a copy of the article. 

Published in Pharma Focus Asia Magazine Issue 44 | September, 2021 | Pages 12 - 16


Please complete form to download PDF
First Name
Last Name
Business Email
Job Title
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy

© 2021 Navitas Life Sciences | A TAKE Solutions Enterprise  
Privacy Policy